Solid Biosciences Inc. Financial Ratios — SLDB Stock

Profitability (USD)

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-44.72	-89.22	-69.32	-96.45	-64.3	-35.78	-34.91	-45.16	-70.53	-82.78
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -	100	100	- -	- -	- -
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	-508.74	-1,196.76	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -	- -	- -	-530.5	-1,226.51	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	62.28	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	-530.01	-1,062.28	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -	- -	- -	-530.01	-1,062.28	- -	- -	- -
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	-530.01	-1,062.28	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	0.97	-19.86	-37.27	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	1	7	5	2	29	26	24	21
ST Debt	- -	- -	- -	- -	2	2	1	3	2	3	2
LT Debt	- -	- -	- -	1	5	3	1	26	24	21	19
Total Debt/EBITDA	- -	- -	- -	-0.01	-0.06	-0.06	-0.03	-0.29	-0.26	-0.19	-0.12
Net Debt/EBITDA	4.36	0.3	0.96	1.17	0.65	1.87	1.72	1.6	0.73	0.63	0.34
Total Debt/EBIT	- -	- -	- -	-0.01	-0.06	-0.06	-0.03	-0.29	-0.25	-0.19	-0.12
Net Debt/EBIT	4.36	0.3	0.95	1.14	0.64	1.79	1.65	1.57	0.71	0.62	0.33
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	-231.21	-374.33	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	-234.66	-376.26	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	-237.08	-381.55	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-121.2	-207.66	-77.76	-142.57	-305.62	-236.31	-205.16	-216.22	-399.38	-415.25	-411.84
Long-Term Debt/Equity (%)	- -	- -	- -	0.69	6.43	2.23	0.27	12.27	18.93	15.42	10.59
Long-Term Debt/Capital (%)	- -	- -	- -	-0.43	-1.66	-0.74	-0.12	-4.86	-3.79	-2.79	-2.03
Long-Term Debt/Total Assets (%)	- -	- -	- -	0.62	4.97	1.72	0.24	9.98	14.52	11.22	8.2
Total Debt/Equity (%)	- -	- -	- -	0.82	8.83	3.9	0.99	13.49	20.77	17.62	11.76
Total Debt/Capital (%)	- -	- -	- -	-0.52	-2.29	-1.29	-0.43	-5.34	-4.15	-3.18	-2.26
Total Debt/Total Assets (%)	- -	- -	- -	0.74	6.83	3.01	0.89	10.97	15.92	12.81	9.1
Net Debt to Equity	143.51	20.27	87.89	-68.99	-95	-117.15	-57.22	-73.41	-58.52	-58.46	-33.28
Net Debt/Capital (%)	58.95	16.84	46.78	30.37	19.74	27.93	20.06	22.53	10.48	9.56	6.01
EBITDA	-7	-26	-54	-74	-116	-83	-69	-97	-102	-127	-178
EBITDA-CapEx	-7	-26	-57	-82	-121	-83	-71	-100	-103	-128	-179
Operating Income (Loss)	-7	-26	-55	-76	-119	-86	-72	-99	-104	-130	-179

Liquidity (USD)

API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	3.98	5.48	6.13	9.81	4.57	6.32	8.8	9.5	8.52	4.92	5.61
Current Ratio	4	5.82	6.27	10.31	4.72	6.49	9.43	9.76	8.94	5.2	6.14
Quick Ratio	3.98	5.48	6.13	9.81	4.57	6.32	8.81	9.5	8.52	4.92	5.61
CFO/Avg Current Liab	- -	-1.93	-4.76	-5.91	-6.03	-2.65	-3.23	-4.25	-5.09	-4.47	-4.9
Common Equity/Total Assets	-121.2	-207.66	-77.76	-142.57	-305.62	-236.31	-205.16	-216.22	-399.38	-415.25	-411.84
Long-Term Debt/Equity (%)	- -	- -	- -	0.69	6.43	2.23	0.27	12.27	18.93	15.42	10.59
Long-Term Debt/Capital (%)	- -	- -	- -	-0.43	-1.66	-0.74	-0.12	-4.86	-3.79	-2.79	-2.03
Long-Term Debt/Total Assets (%)	- -	- -	- -	0.62	4.97	1.72	0.24	9.98	14.52	11.22	8.2
Total Debt/Equity (%)	- -	- -	- -	0.82	8.83	3.9	0.99	13.49	20.77	17.62	11.76
Total Debt/Capital (%)	- -	- -	- -	-0.52	-2.29	-1.29	-0.43	-5.34	-4.15	-3.18	-2.26
Total Debt/Total Assets (%)	- -	- -	- -	0.74	6.83	3.01	0.89	10.97	15.92	12.81	9.1
CFO/Total Liabilities	-5.56	-25.62	-31.91	-487.01	-395.82	-144.82	-321.75	-201.66	-244.89	-194.52	-297.52
CFO/CapEx	- -	-51.33	-18.99	-9.03	-21.13	-62.96	-60.71	-32.5	-62.17	-152.92	-135.55
Altman's Z-Score	-1.19	-4.03	-3.72	34.32	-2.7	2.01	1.83	-2.78	-4.94	-5.37	-1.78

Working Capital (USD)

API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	247.64	147.16	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	1.47	2.48	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	891	179	394	187	46	122	163	494
- Cash & Cash Equivalents	29	8	52	86	76	155	119	155	74	80	60
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	48	46	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	1	7	5	2	29	26	24	21
Enterprise Value	-8	9	-69	770	103	244	-19	-139	25	39	327
Total Capital	-20	-38	-59	-198	-309	-399	-475	-534	-632	-759	-937
Total Debt/Capital (%)	- -	- -	- -	-0.52	-2.29	-1.29	-0.43	-5.34	-4.15	-3.18	-2.26
Total Debt / EV	- -	- -	- -	- -	0.07	0.02	-0.11	-0.2	1.06	0.63	0.06
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	891	179	394	187	46	122	163	494
Diluted Enterprise Value	19	39	-52	806	110	244	70	-81	74	107	455
EV per Share	- -	6.88	- -	347.24	38.29	70.5	- -	- -	1.24	0.94	3.74
TTM Sales	- -	- -	- -	- -	- -	- -	14	8	- -	- -	- -
TTM EBITDA	-7	-26	-54	-74	-116	-83	-69	-97	-102	-127	-178
TTM Operating Income	-7	-26	-55	-76	-119	-86	-72	-99	-104	-130	-179
TTM Cash Flow to Firm	-4	-20	-43	-70	-93	-57	-78	-98	-94	-100	-156
TTM Free Cash Flow to Firm	-4	-20	-41	-62	-88	-56	-76	-95	-92	-99	-155

Multiples (USD)

API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	-14.28	-2.03	-7.07	-2.44	-0.48	-1.32	-1.64	-3.18
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-8	9	-69	770	103	244	-19	-139	25	39	327
Low Price	- -	- -	- -	102.45	41.25	28.95	23.85	5.21	1.81	3.85	2.41
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	-13.14	-3.31	-1.89	-6.1	-1.1	-0.97	-2.61	-2.4
Price/Earnings High	- -	- -	- -	-24.39	-11.29	-4.85	-17.13	-2.73	-1.7	-4.93	-3.7
Price/Earnings Low	- -	- -	- -	-3.04	-0.95	-1.14	-2.35	-0.52	-0.37	-1.26	-1.21
Price/Book Value	- -	- -	- -	-4.48	-0.57	-0.97	-0.39	-0.08	-0.19	-0.21	-0.52
Price/Book Value Average	- -	- -	- -	-4.94	-1.23	-0.41	-0.92	-0.17	-0.14	-0.41	-0.44
Price/Book Value High	- -	- -	- -	-9.17	-4.19	-1.06	-2.59	-0.42	-0.25	-0.78	-0.67
Price/Book Value Low	- -	- -	- -	-1.14	-0.35	-0.25	-0.36	-0.08	-0.05	-0.2	-0.22
Price/Tangible Book Value	- -	- -	- -	7.12	2.24	2.98	0.9	0.22	0.97	1.19	2.74
Price/Tangible Book Value Average	- -	- -	- -	7.85	4.85	1.26	2.11	0.45	0.73	2.37	2.33
Price/Tangible Book Value High	- -	- -	- -	14.57	16.53	3.24	5.94	1.11	1.29	4.48	3.58
Price/Tangible Book Value Low	- -	- -	- -	1.81	1.38	0.76	0.82	0.21	0.28	1.14	1.17
Price/Sales	- -	- -	- -	- -	- -	- -	13.72	5.66	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	32.32	11.72	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	90.78	28.95	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	12.46	5.48	- -	- -	- -
Price/Cash Flow	- -	- -	- -	-12.7	-1.93	-6.96	-2.4	-0.47	-1.3	-1.63	-3.16
Price/Cash Flow Average	- -	- -	- -	-14.01	-4.19	-2.95	-5.66	-0.97	-0.99	-3.25	-2.68
Price/Cash Flow High	- -	- -	- -	-25.99	-14.28	-7.56	-15.9	-2.39	-1.73	-6.14	-4.13
Price/Cash Flow Low	- -	- -	- -	-3.24	-1.2	-1.77	-2.18	-0.45	-0.38	-1.57	-1.35
Price/Free Cash Flow Average	- -	- -	- -	-15.75	-4.4	-2.99	-5.76	-1	-1	-3.27	-2.7
Price/Free Cash Flow High	- -	- -	- -	-29.22	-14.98	-7.68	-16.17	-2.47	-1.76	-6.18	-4.16
Price/Free Cash Flow Low	- -	- -	- -	-3.64	-1.25	-1.8	-2.22	-0.47	-0.39	-1.58	-1.36
EV/Sales Average	- -	- -	- -	- -	- -	- -	23.72	- -	- -	- -	- -
EV/Sales High	- -	- -	- -	- -	- -	- -	82.18	13.28	- -	- -	- -
EV/Sales Low	- -	- -	- -	- -	- -	- -	3.87	- -	- -	- -	- -
EV/EBITDA Average	-2.89	-1.52	0.96	-12.11	-2.74	-0.21	-4.66	0.33	-0.44	-2.11	-2.14
EV/EBITDA High	-2.89	-1.52	0.96	-23.46	-10.77	-3.37	-16.15	-1.11	-1.13	-4.39	-3.41
EV/EBITDA Low	-2.89	-1.52	0.96	-1.91	-0.36	0.6	-0.76	0.85	0.12	-0.79	-0.97
EV/EBIT Average	-2.89	-1.52	0.95	-11.86	-2.68	-0.2	-4.47	0.32	-0.43	-2.07	-2.12
EV/EBIT High	-2.89	-1.52	0.95	-22.97	-10.51	-3.22	-15.49	-1.08	-1.11	-4.3	-3.38
EV/EBIT Low	-2.89	-1.52	0.95	-1.87	-0.35	0.57	-0.73	0.83	0.11	-0.78	-0.96
Last Price	- -	- -	- -	402	66.75	113.7	26.25	5.38	6.14	4	5.64
High Price	- -	- -	- -	822.6	492.75	123.6	173.7	27.53	8.2	15.05	7.37
Enterprise Value Average	19	39	-52	898	320	17	323	-32	45	269	380
Enterprise Value High	19	39	-52	1,739	1,255	278	1,119	108	115	558	606
Enterprise Value Low	19	39	-52	142	42	-49	53	-82	-12	101	172

Shares Outstanding	2	2	2	2	3	6	7	20	20	40	79
Diluted Weighted Avg Shares	1	1	2	2	3	3	7	9	20	41	88
Basic Weighted Avg Shares	1	1	2	2	3	3	7	9	20	41	88
Revenue per Share	- -	- -	- -	- -	- -	- -	1.91	0.95	- -	- -	- -
EBITDA per Share	-5.12	-19.9	-25.32	-33.43	-43.37	-23.84	-9.73	-11.38	-5.12	-3.12	-2.03
Operating Income per Share	-5.12	-19.95	-25.53	-34.13	-44.42	-24.97	-10.15	-11.66	-5.25	-3.18	-2.05
Basic EPS, GAAP	-5.03	-13.44	-17.4	-33.73	-43.64	-25.5	-10.14	-10.1	-4.83	-3.06	-1.99
Basic EPS from Cont Ops	-5.2	-18.54	-24.75	-33.73	-43.64	-25.5	-10.14	-10.1	-4.83	-3.06	-1.99
Diluted EPS, GAAP	-5.03	-13.44	-17.4	-33.73	-43.64	-25.5	-10.14	-10.1	-4.83	-3.06	-1.99
Diluted EPS from Cont Ops	-5.2	-18.54	-24.75	-33.73	-43.64	-25.5	-10.14	-10.1	-4.83	-3.06	-1.99
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-3.28	-15.69	-20.12	-31.66	-34.52	-16.35	-10.92	-11.51	-4.74	-2.45	-1.79
Free Cash Flow per Basic Share	-3.28	-16	-21.18	-35.16	-36.15	-16.61	-11.1	-11.86	-4.81	-2.47	-1.8
Cash & Equivalents per Share	43.2	29.37	32.16	55.23	31.1	44.69	29.19	25.11	6.22	3.65	2.15
Book Value per Share	-52.65	-65.81	-27.57	-89.75	-117.74	-116.82	-66.98	-66.11	-33.13	-19.19	-10.94
Tangible Book Value per Share	-15.54	-29.55	-27.58	56.45	29.8	38.15	29.25	24.87	6.36	3.36	2.06

Solid Biosciences Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)